TC Biopharm Holdings PLC-ADRTCBPY
13F holders, Q2 2025 (June 30)2holders
0new positions
0sold out
$0.35avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding TC Biopharm Holdings PLC-ADR (TCBPY) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were GAMMA Investing LLC ($82) and Rhumbline Advisers ($4).
- Company
- TC Biopharm Holdings PLC-ADR
- CUSIP
- 87807D608
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 9,368 shares sold, net −9,368 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| GAMMA Investing LLC | 0.00% | Reduce -97.6% | 230 | $82 |
| Rhumbline Advisers | 0.00% | Reduce -75.4% | 15 | $4 |
"% of holder's portfolio" is TCBPY's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC-ADR the manager owns.